SkinHealth Systems Inc. announced the promotion of its Chief Financial Officer, Michael Monahan, to Chief Financial and Operating Officer effective September 3, 2026. In this expanded role, Mr. Monahan will oversee all financial operations as well as supply chain, manufacturing, logistics, and customer experience functions. His base salary will increase from $515,000 to $555,000 starting September 15, 2026. The company confirmed there are no special arrangements or family relationships associated with this appointment. SkinHealth Systems Inc. operates in the dermatological health and wellness industry.

SkinHealth Systems Inc. reported second quarter 2026 financial results showing a net loss of $2.7 million, compared to net income of $19.7 million in the prior year period. Total net sales decreased 7.8% to $72.1 million from $78.2 million, driven by lower delivery systems and consumables revenue. Delivery system units sold dropped to 770 from 957 year-over-year. Gross margin improved to 68.4% from 62.8%, while adjusted EBITDA rose to $17.0 million from $13.9 million, exceeding guidance due to cost discipline and higher margins. The company revised its full-year 2026 net sales guidance down to $280–$290 million and adjusted EBITDA guidance to $39–$46 million. SkinHealth Systems operates in the medical aesthetics industry, providing integrated skincare solutions including Hydrafacial devices and consumables.

SkinHealth Systems Inc. entered into a settlement agreement to resolve a securities class action lawsuit, Alghazwi v. The Beauty Health Company, et al., in the Central District of California. The total cash settlement of $18,000,000 will be funded by $3,000,000 from the company's own funds and $15,000,000 from insurance proceeds. The settlement is subject to court approval and involves the resolution of claims against the company and individual defendants Andrew Stanleick and Liyuan Woo. SkinHealth Systems Inc. operates in the consumer beauty and skin health industry.